Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice

Neuromuscular Disorders

Volumn 19, Issue 7, 2009, Pages 489-499

  Matsakas, Antonios ^a   Foster, Keith ^b   Otto, Anthony ^a   Macharia, Raymond ^c   Elashry, Mohamed I ^a   Feist, Simon ^a   Graham, Ian ^b   Foster, Helen ^b   Yaworsky, Paul ^d   Walsh, Frank ^d   Dickson, George ^b   Patel, Ketan ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

^d PFIZER INC   (United States)

Author keywords

Hypertrophy; Muscle; Myostatin; Physiology; Propeptide; Satellite cell; Skeletal; Therapy

Indexed keywords

MYOSTATIN PROPEPTIDE; PARVOVIRUS VECTOR; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; EXTENSOR DIGITORUM LONGUS MUSCLE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; GENE MUTATION; MALE; MOUSE; MUSCLE CELL; MUSCLE FORCE; MUSCLE GROWTH; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; RECTUS FEMORIS MUSCLE; TIBIALIS ANTERIOR MUSCLE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

AGE FACTORS; ANIMALS; CELL ENLARGEMENT; CELL NUCLEUS SIZE; DISEASE MODELS, ANIMAL; GENE THERAPY; GENETIC VECTORS; HYPERTROPHY; INJECTIONS, INTRAVENOUS; MALE; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOSTATIN; PEPTIDES; TREATMENT OUTCOME;

EID: 67649668906     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.06.367     Document Type: Article

References (55)

1. Hornberger T.A., Sukhija K.B., and Chien S. Regulation of mTOR by mechanically induced signaling events in skeletal muscle. Cell Cycle 5 13 (2006) 1391-1396
2. Matsakas A., and Patel K. Intracellular signalling pathways regulating the adaptation of skeletal muscle to exercise and nutritional changes. Histol Histopathol 24 2 (2009) 209-222
3. Thomas D.R. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 26 4 (2007) 389-399
4. Matsakas A., and Patel K. Skeletal muscle fibre plasticity in response to selected environmental and physiological stimuli. Histol Histopathol 24 5 (2009) 611-629
5. McPherron A.C., Lawler A.M., and Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387 6628 (1997) 83-90
6. McPherron A.C., and Lee S.J. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 94 23 (1997) 12457-12461
7. Clop A., Marcq F., Takeda H., et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38 7 (2006) 813-818
8. Grobet L., Martin L.J., Poncelet D., et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 17 1 (1997) 71-74
9. Schuelke M., Wagner K.R., Stolz L.E., et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350 26 (2004) 2682-2688
10. Shelton G.D., and Engvall E. Gross muscle hypertrophy in whippet dogs is caused by a mutation in the myostatin gene. Neuromuscul Disord 17 9-10 (2007) 721-722
11. Lee S.N., Prodhomme E., and Lindberg I. Prohormone convertase 1 (PC1) processing and sorting: effect of PC1 propeptide and proSAAS. J Endocrinol 182 2 (2004) 353-364
12. Tsuchida K. The role of myostatin and bone morphogenetic proteins in muscular disorders. Expert Opin Biol Ther 6 2 (2006) 147-154
13. Thomas M., Langley B., Berry C., et al. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275 51 (2000) 40235-40243
14. Yang W., Zhang Y., Li Y., Wu Z., and Zhu D. Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1. J Biol Chem 282 6 (2007) 3799-3808
15. Matsakas A., and Diel P. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis. Int J Sports Med 26 2 (2005) 83-89
16. Gonzalez-Cadavid N.F., Taylor W.E., Yarasheski K., et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci USA 95 25 (1998) 14938-14943
17. Yarasheski K.E., Bhasin S., Sinha-Hikim I., Pak-Loduca J., and Gonzalez-Cadavid N.F. Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J Nutr Health Aging 6 5 (2002) 343-348
18. McMahon C.D., Popovic L., Oldham J.M., et al. Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension. Am J Physiol Endocrinol Metab 285 1 (2003) E82-E87
19. Hill J.J., Davies M.V., Pearson A.A., et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277 43 (2002) 40735-40741
20. Lee S.J., and McPherron A.C. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98 16 (2001) 9306-9311
21. Thies R.S., Chen T., Davies M.V., et al. GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18 4 (2001) 251-259
22. Zimmers T.A., Davies M.V., Koniaris L.G., et al. Induction of cachexia in mice by systemically administered myostatin. Science 296 5572 (2002) 1486-1488
23. Hill J.J., Qiu Y., Hewick R.M., and Wolfman N.M. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol 17 6 (2003) 1144-1154
24. Patel K., and Amthor H. The function of myostatin and strategies of myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle. Neuromuscul Disord 15 2 (2005) 117-126
25. Whittemore L.A., Song K., Li X., et al. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 300 4 (2003) 965-971
26. Zhu X., Hadhazy M., Wehling M., Tidball J.G., and McNally E.M. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett 474 1 (2000) 71-75
27. Nishi M., Yasue A., Nishimatu S., et al. A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle. Biochem Biophys Res Commun 293 1 (2002) 247-251
28. Grobet L., Pirottin D., Farnir F., et al. Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene. Genesis 35 4 (2003) 227-238
29. Yang J., Ratovitski T., Brady J.P., Solomon M.B., Wells K.D., and Wall R.J. Expression of myostatin pro domain results in muscular transgenic mice. Mol Reprod Dev 60 3 (2001) 351-361
30. Reisz-Porszasz S., Bhasin S., Artaza J.N., et al. Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab 285 4 (2003) E876-E888
31. Bogdanovich S., Perkins K.J., Krag T.O., Whittemore L.A., and Khurana T.S. Myostatin propeptide-mediated amelioration of dystrophic pathophysiology. FASEB J 19 6 (2005) 543-549
32. Haidet A.M., Rizo L., Handy C., et al. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci USA 105 11 (2008) 4318-4322
33. Nakatani M., Takehara Y., Sugino H., et al. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J 22 2 (2008) 477-487
34. Bartoli M., Poupiot J., Vulin A., et al. AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency. Gene Ther 14 9 (2007) 733-740
35. Qiao C., Li J., Jiang J., et al. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice. Hum Gene Ther 19 3 (2008) 241-254
36. Qiao C., Li J., Zheng H., et al. Hydrodynamic limb vein injection of AAV8 canine myostatin propeptide gene in normal dogs enhances muscle growth. Hum Gene Ther 20 1 (2008) 1-10
37. Krivickas L.S., Walsh R., and Amato A.A. Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029. Muscle Nerve 39 1 (2009) 3-9
38. Wagner K.R., Fleckenstein J.L., Amato A.A., et al. A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63 5 (2008) 561-571
39. Wolfman N.M., McPherron A.C., Pappano W.N., et al. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci USA 100 26 (2003) 15842-15846
40. Yue Y., and Dongsheng D. Development of multiple cloning site cis-vectors for recombinant adeno-associated virus production. Biotechniques 33 3 (2002) 672 674, 676-678
41. Foster K., Graham I.R., Otto A., et al. Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle. Rejuvenation Res 12 2 (2009) 85-94
42. Otto A., Schmidt C., Luke G., et al. Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration. J Cell Sci 121 Pt. 17 (2008) 2939-2950
43. Amthor H., Macharia R., Navarrete R., et al. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci USA 104 6 (2007) 1835-1840
44. Mendias C.L., Marcin J.E., Calerdon D.R., and Faulkner J.A. Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J Appl Physiol 101 3 (2006) 898-905
45. Girgenrath S., Song K., and Whittemore L.A. Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle. Muscle Nerve 31 1 (2005) 34-40
46. Steelman C.A., Recknor J.C., Nettleton D., and Reecy J.M. Transcriptional profiling of myostatin-knockout mice implicates Wnt signaling in postnatal skeletal muscle growth and hypertrophy. FASEB J 20 3 (2006) 580-582
47. Carlson C.J., Booth F.W., and Gordon S.E. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol 277 2 Pt. 2 (1999) R601-R606
48. Collins C.A., Olsen I., Zammit P.S., et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122 2 (2005) 289-301
49. Heslop L., Morgan J.E., and Partridge T.A. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sci 113 Pt. 12 (2000) 2299-2308
50. Zammit P.S., Heslop L., Hudon V., et al. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp Cell Res 281 1 (2002) 39-49
51. Amthor H., Otto A., Vulin A., et al. Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. Proc Natl Acad Sci USA 106 18 (2009) 7479-7484
52. Mosher D.S., Quignon P., Bustamante C.D., et al. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet 3 5 (2007) e79
53. Degens H. Age-related skeletal muscle dysfunction: causes and mechanisms. J Musculoskelet Neuronal Interact 7 3 (2007) 246-252
54. Rehfeldt C., Ott G., Gerrard D.E., et al. Effects of the compact mutant myostatin allele Mstn (Cmpt-dl1Abc) introgressed into a high growth mouse line on skeletal muscle cellularity. J Muscle Res Cell Motil 26 2-3 (2005) 103-112
55. 2+ sinks in rat extraocular muscles: a novel regulatory influence on contractile function and metabolism. Invest Ophthalmol Vis Sci 46 12 (2005) 4541-4547